RAPTOR PHARMACEUTICAL CORP - COM (RPTP)

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
50,312,201
Share change
+2,690,918
Total reported value
$261,622,800
Put/Call ratio
139%
Price per share
$5.20
Number of holders
108
Value change
+$10,979,878
Number of buys
56
Number of sells
54

Institutional Holders of RAPTOR PHARMACEUTICAL CORP - COM (RPTP) as of Q4 2015

As of 31 Dec 2015, RAPTOR PHARMACEUTICAL CORP - COM (RPTP) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,312,201 shares. The largest 10 holders included CREDIT SUISSE AG/, FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, Broadfin Capital, LLC, D. E. Shaw & Co., Inc., BlackRock Institutional Trust Company, N.A., and MILLENNIUM MANAGEMENT LLC. This page lists 108 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.